Skip to content
Call organization+972 3530 9292
Clinical specialist

Naama Peltz Sinvani, MD

Endocrinologist · Sheba Longevity CenterEndocrinology, diabetes, bone metabolism, neuroendocrine tumors, longevity hormonal-metabolic care

Endocrinologist covering hormonal, metabolic, bone, diabetes, and neuroendocrine signals in Sheba's assessment

4.9 · 420 reviews
Portrait of Naama Peltz Sinvani, MD

At a glance

Visit type
In person
Languages
English, Hebrew

Practice

About

Naama Peltz Sinvani, MD is an endocrinologist on the Sheba Longevity Center team and an attending in Sheba's Division of Endocrinology, Diabetes and Metabolism. She earned her MD at Tel Aviv University's Sackler School of Medicine, completed internal-medicine residency from 2013-2018, and completed Sheba's endocrinology, diabetes, and metabolism fellowship from 2019-2021. Her publication record spans bone-density methodology, pregnancy- and lactation-induced osteoporosis, continuous glucose monitoring in older adults with type 2 diabetes, neuroendocrine tumors, hyperparathyroidism, and low ALT as a long-term mortality marker.

Reviews

MedReviews4.9(420 reviews)Checked

Editorial summary

The ten displayed reviews describe positive experiences, particularly professional care, thorough assessment and clear explanations. Several also mention kindness or attentive listening.

What people mention

  • Professionalism7 mentions
    positive
  • Thorough assessment5 mentions
    positive
  • Clear explanations6 mentions
    positive
  • Kindness and empathy5 mentions
    positive
  • Attentive listening2 mentions
    positive

Approach

Signature approach

Peltz Sinvani covers the hormonal and metabolic side of Sheba's longevity workup. Her research background helps connect bone health, glucose patterns, endocrine tumors, thyroid/parathyroid questions, and diabetes risk to the broader 450+ biomarker assessment rather than treating each lab as an isolated result.

What sets them apart

  • Sheba-trained endocrinology pathway. Internal medicine residency and endocrinology fellowship both run through the same hospital where she now practices.
  • Bone and diabetes research. First-author and co-authored work covers osteoporosis, bone-density methods, CGM, and older-adult diabetes markers.
  • Broad endocrine range. Publications span neuroendocrine tumors, hyperparathyroidism, ALT mortality markers, and metabolic disease.

Focus

Specialties

Hormone OptimizationMetabolic Health

Who they see

General Adult LongevityAdults 65+Metabolic & Weight ManagementWomen in Perimenopause & Menopause

Conditions treated

Type 1 diabetesType 2 diabetesGestational diabetesOsteoporosisOsteopeniaHypercalcemiaHypocalcemiaParathyroid disordersHypothyroidismHyperthyroidismThyroid nodulesPolycystic ovary syndromeAmenorrheaMenopauseAdrenal disordersPituitary disorders

Training

Education

  • MD, Medicine
    Sackler School of Medicine, Tel Aviv University
  • MD, Medicine, graduated with honors
    Semmelweis University, Budapest, Hungary (2006–2011)
  • BSc, Chemistry
    Bar-Ilan University, Ramat Gan, Israel (2003–2006)

Residency

  • Internal Medicine
    Sheba Medical Center (2013–2018)
  • Endocrinology, Diabetes and Metabolism
    Sheba Medical Center (2019–2021)

Fellowship

  • Endocrinology, Diabetes, and Metabolism
    Sheba Medical Center, Tel HaShomer

Board certifications

  • Internal Medicine

    Israeli Medical Association

    Board certification in internal medicine — diagnosis and treatment of adult medical conditions across organ systems.

  • Endocrinology, Diabetes, and Metabolism

    Israeli Medical Association

    Sub-specialty board certification in endocrinology — hormonal disorders, diabetes, thyroid, parathyroid, bone metabolism, and neuroendocrine tumors.

Published work

Elsewhere

Media and talks

Collaboration

  • Liana Tripto-Shkolnik, MD
    Sheba endocrinology colleague; frequent co-author across the bone-density and pregnancy-and-lactation-induced osteoporosis research line
  • Amit Tirosh, MD
    Senior author on the 2021 lung-neuroendocrine-tumor paper and the 2026 hyperparathyroidism paper; head of Sheba's neuroendocrine-tumor program
  • Tali Cukierman-Yaffe, MD
    Co-author on the diabetes / continuous glucose monitoring research in older adults with type 2 diabetes

Before You Book

  • Endocrine focus. Relevant for hormonal aging, bone density, diabetes, thyroid/parathyroid, metabolic, and neuroendocrine questions.
  • Team assignment. Ask whether endocrine review is part of your visit and which specialist is assigned.
  • Language. English and Hebrew are supported by publication and work context; confirm language needs with Sheba.

Verification

Profile updated

Primary sourcehttps://longevity.sheba.co.il/en/naama-peltz-sinvani

Where a detail is missing, it means we have not verified it—not that the answer is no. Directory listings are for informational purposes only. Inclusion does not constitute endorsement. Verify credentials and qualifications independently.